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Background: In 2005 the International Study Group for Pancreatic Fistula (ISGPF) created a definition
and grading system for pancreatic fistulae (PF) in which grade C denotes the most severe and potentially
life-threatening type. Factors and outcomes associated with grade C fistulae have been ill defined.
Methods: Systematic searches of PubMed and EMBASE were conducted by two independent review-
ers utilizing the keywords ‘pancreaticoduodenectomy’ (PD) and ‘pancreatic fistula’. Inclusion criteria
were: (i) a sample of 100 patients; (ii) consecutive accrual of all pathologies, and (iii) use of the ISGPF
definition and grading system. Quality appraisal and data extraction were performed using pilot-tested
templates.
Results: Fourteen articles describing a total of 2706 PDs met the study entrance criteria. Pancreatic
fistulae occurred in 479 patients (18%) and included 71 grade C PF that were directly responsible for 25
deaths (35% mortality rate). Only two studies analysed risk factors; these found soft pancreatic texture
and histology other than adenocarcinoma to be the most common risk factors. Ten studies reported
management strategies and indicated that 51% of patients required reoperation.
Conclusions: Grade C PF: (i) accounts for 15% of fistulae following PD and has an associated mortality
rate of 35%; (ii) occurs most commonly in pathology associated with a soft remnant, and (iii) requires
reoperation in approximately one half of patients. The published literature incompletely describes grade
C PF.
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Introduction
The development of a pancreatic fistula (PF) following pancreati-
coduodenectomy (PD) remains common, with reported inci-
dences of 2–25% in the recent literature.1–9 This wide variation
in incidence largely reflects the historical lack of a universally
accepted definition. In 2005, the International Study Group for
Pancreatic Fistula (ISGPF) proposed guidelines for consistent
stratification which indicated that a PF was defined as present by
the drain output of any measurable amount on or after postop-
erative day 3 with an amylase content greater than three times that
of serum.10 This broad definition includes a spectrum of patients
ranging from the clinically asymptomatic to the critically ill and
therefore a grading system (A, B and C) was developed (Table 1).
A grade A PF is transient and has no clinical impact. A grade B PF
requires a change in management; patients are frequently main-
tained on a nil by mouth regimen with supplemental nutrition,
may require antibiotics and/or therapeutic procedures, and often
experience delayed discharge. The most severe grade C PF is asso-
ciated with a deterioration in clinical status that requires intensive
care management. These PF may require reoperation and carry a
distinct risk for mortality.
The definition and grading system proposed by the ISGPF was
readily accepted by pancreatic surgeons and over the last 5 years
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has become the predominant classification scheme used in the
pancreatic literature. Although numbers of grade C PF are
now consistently reported, dramatically different outcomes and
mortality rates in the range of 0–40% have been described.11,12
Additionally, risk factors and appropriate management strategies
for grade C PF have been poorly defined. Thus, a systematic
review of the pancreatic surgical literature was performed, firstly
to determine the incidence and outcome of grade C PF, and,
secondly, to elucidate potential risk factors for the development of
PF and surgical management strategies when it occurs.
Materials and methods
Two researchers independently conducted searches of PubMed
and EMBASE using the keywords ‘pancreaticoduodenectomy’ and
‘pancreatic fistula’. The results were limited to studies involving
adult humans, reported in English, and published during the 5
years (1 August 2005 to 31 July 2010) following the publication of
the ISGPF definition. Criteria used for inclusion required that
studies: (i) refer to 100 patients; (ii) demonstrate the consecu-
tive accrual of unselected patients including all pathologic diag-
noses, and (iii) show use of the ISGPF definition and grading
system. The titles and abstracts of studies that fulfilled these cri-
teria were reviewed and a list was compiled of potential articles.
References within these publications were also reviewed to ensure
that no salient articles were excluded from this review. Next, the
manuscripts of the potentially relevant articles were analysed.
Publications that did not meet the inclusion criteria were
excluded. If the two reviewers disagreed on whether or not to
include a given article, the inclusion criteria were discussed in
detail and a unanimous decision was reached. Quality appraisal
was performed on all articles that met the inclusion criteria using
a pilot-tested template that included data on: first author; year
of publication; participating institutions; type of study; study
design; corresponding level of evidence; PF definition, and
whether PF had been defined and graded by independent
reviewers.13 A database was created in which data on the study
time period, total number of patients, predominant pathologies,
type of reconstruction (pancreaticojejunostomy vs. pancreatico-
gastrostomy), number of PF, grade of PF, number of deaths from
grade C PF, potential risk factors for fistula development and
grade C PF operative management were entered for each study.
Results
The PubMed and EMBASE searches yielded 188 references. These
included 12 studies in the non-English literature, which were
excluded; most of these were small series that would not have met
the present entrance criteria. The review of titles and abstracts
identified 153 studies that did not meet baseline criteria; these
were excluded, leaving 35 potentially relevant manuscripts. The
bibliographies of these publications were reviewed to ensure that
other pertinent articles were not excluded. No further publica-
tions were identified. Of the 35 manuscripts reviewed, 14 were
found to fulfil all of the inclusion criteria (Fig. 1).11,14–26 The most
common reasons for exclusion in the remaining 21 publications
were failure to following the ISGPF grading system and/or the
exclusion of certain patient populations.
Thirteen articles were observational in design. These included
11 case series11,14–17,19,21,23–26 and two cohort studies.18,22 One study
used an experimental design and was a randomized controlled
trial comparing a new pancreaticogastrostomy technique with
conventional pancreaticojejunostomy.20 The ISGPF definition and
grading system were used in all 14 studies. No articles used inde-
pendent reviews to identify and grade PF (Table 2).
The studies covered a total of 2706 PDs performed at 18 differ-
ent institutions across North America, Europe andAsia. Themean
duration of the studies reviewed was 5.3 years. The mean number
of PDs performed annually was 34. Thirteen of the 14 studies
reported the pancreatic anastomotic technique, which involved
pancreaticojejunostomy in 1472 cases (73%) and pancreaticogas-
trostomy in the remainder. Pancreatic fistulae occurred in 479
Table 1 Characteristics of grade A, B and C pancreatic fistulae published by Bassi et al.10
Grade of fistula
A B C
Clinical condition Well Often well Poor, appears ill
Specific treatmenta No Yes/No Yes
US/CT (if obtained) Negative Negative/positive Positive
Persistent drainage (after 3 weeks)b No Usually yes Yes
Reoperation No No Yes
Death related to postoperative PF No No Possibly yes
Signs of infections No Yes Yes
Sepsis No No Yes
Readmission No Yes/No Yes/No
aPartial (peripheral) or total parenteral nutrition, antibiotics, enteral nutrition, somatostatin analogue and/or minimal invasive drainage.
bWith or without a drain in situ.
US, ultrasonography; CT, computed tomography.
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(18%) patients. Of these PF, 220 (46%) were grade A, 188 (39%)
grade B, and 71 (15%) grade C. The overall grade C PF rate was
2.6%. Grade C PF was directly responsible for 25 deaths, equating
to a mortality rate of 35%.
Data relevant to potential risk factors and surgical management
were also extracted. Only two studies attempted to identify risk
factors for grade C PF.11,17 Both performed statistical analyses of
multiple patient, pancreas and surgery-related factors potentially
associated with this complication.One study attempted to identify
factors that distinguished grade A and B PF from grade C PF.
Univariate analysis showed that perioperative blood transfusion,
soft pancreatic texture and postoperative bleeding were associated
with grade C PF, but on multivariate analysis only soft pancreatic
texture approached significance (P = 0.06).11 In the second study,
the authors were unable to identify any factors that distinguished
grade C from grade B PF because of the small number of grade C
fistulae identified in the study.17 However, compared with patients
with grade A fistulae, those with grade B or C fistulae were
statistically more likely to have small duct size, soft gland
texture, ampullary, duodenal, cystic or islet cell pathology and
increased intraoperative blood loss as determined by multivariate
analysis. Details of operative management were included in 10
studies.11,14,16,18–21,23,25,26 Twenty-eight of 55 (51%) patients required
remedial surgery for a grade C PF. Clear descriptions of the
operative technique were given for 26 of the 28 patients: 14
underwent drainage, six underwent anastomotic revision, five
underwent completion pancreatectomy, and one underwent a
partial pancreatic remnant resection.
Discussion
Pancreatic fistulae remain problematic following elective PD
despite advances in surgical technique and perioperative care.
With regard to the most severe grade C fistulae, data relative to
risk factors for their development, as well as to their operative and
non-operative management, have been sparse. Further, outcome
measures including factors such as length of stay, delay in func-
tional recovery, delay in initiation of adjuvant therapy, and mor-
tality following these devastating fistulae have been incompletely
characterized. The present systematic review of the pancreatic
surgical literature identified 14 articles from tertiary referral
centres across several countries that met predefined criteria and
helped to preliminarily define grade C PF. The findings of this
systematic review suggest trends particular to grade C PF and offer
a framework for future study.
Pancreatic fistulae are among the most common complications
after PD; in this review PF occurred in 18% of patients and it is
not uncommon in even the more recent literature.27 Grade C PF,
although infrequent, must be anticipated; in the present study it
accounted for 15% of all PF and occurred at an overall incidence
of 2.6% (range 0–4.9%) in patients undergoing Whipple proce-
dures. A recent survey by 11 high-volume Japanese centres
reported an identical incidence of grade C PF.28 By definition, the
development of a grade C fistula may lead to death; the mortality
rate of 35% identified in this review is not dissimilar to the 39%
reported by Fuks et al.11 As recent large series from high-volume
centres have reported overall mortality rates of <2% following PD,
it may be inferred that grade C fistula is a significant contributor
to death in many of these patients.29,30 These findings suggest that
attention should be focused on the aetiology and treatment of this
particular complication in an attempt to reduce its incidence.
Such a focusmight offer an opportunity to significantly reduce the
remaining minimal mortality associated with PD.
Risk factors for the development of grade C fistulae in particu-
lar have not been well addressed in the literature. Only two of the
articles included in this review attempted to elucidate factors asso-
ciated with these severe fistulae, one of which was inclusive of
both grade B and C fistulae.11,17 A soft pancreatic remnant, small
Literature search yielded
188 articles
188 articles screened
35 full-text articles
assessed
14 articles included
153 articles excludeda
21 full-text articles
excludedb
Figure 1 Literature search flow diagram. A total of 174 articles were
excluded after review of the abstracta or full textb because they failed
to meet at least one of the inclusion criteria
Table 2 Articles meeting the inclusion criteria for this review
Authors Year of
publication
Study design Level of
evidence
Akamatsu et al.25 2010 Case series IV
Gaujoux et al.24 2010 Case series IV
Grobmyer et al.23 2010 Case series IV
Fuks et al.11 2009 Case series IV
Kawai et al.26 2009 Case series IV
Perwaiz et al.22 2009 Cohort study III
Rosso et al.21 2009 Case series IV
Fernandez-Cruz et al.20 2008 Randomized
controlled trial
I
Pratt et al.17 2008 Case series IV
Satoi et al.18 2008 Cohort study III
Sledzinski et al.19 2008 Case series IV
Cheng et al.15 2007 Case series IV
Lermite et al.14 2007 Case series IV
Liang et al.16 2007 Case series IV
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duct size, excessive perioperative blood loss and pathology includ-
ing ampullary, duodenal, cystic and islet cell neoplasms were most
often associated with clinically relevant fistulae. Similar observa-
tions have been reported by other authors with reference to all PF
without stratification to grades A, B or C.12,31,32 Kawai and col-
leagues found that a soft remnant and small duct size were sig-
nificantly associated with grade B and C fistulae.28 Yeo et al. found
on both univariate and multivariate analysis that ampullary and
duodenal carcinomas were significantly associated with the devel-
opment of PF.31 These trends are not surprising given that these
lesions, along with cystic and islet cell neoplasms, infrequently
lead to pancreatic duct obstruction or dilation and gland fibrosis,
thereby resulting in a soft remnant for reconstruction. Excessive
intraoperative blood loss, obesity and a fatty pancreas have also
been associated with a higher risk for the development of PF,
although the relationships between these factors and grade C
fistulae specifically are less well defined.17,21,24,28,33
Most PF can be managed non-operatively, but a significant
number of grade C PF do require reoperative surgical interven-
tion. Options include peripancreatic drainage with or without
attempted repair of the site of leakage, construction of a new
pancreaticoenteric anastomosis, resection of the anastomosis with
remnant ligation, and completion pancreatectomy. The most
common procedure in this review was peripancreatic drainage
with or without attempted repair of the anastomosis, which was
performed in over half of all patients. The details contained within
the manuscripts were insufficient to elucidate whether any par-
ticular procedure yielded superior outcomes. Schlitt and col-
leagues reported on 31 patients with clinically significant leakage
of the pancreatic anastomosis, all but two of whom underwent
surgical remediation.34 Ten patients underwent completion pan-
createctomy and eight of them died. Sixteen patients underwent
either repair of the site of leakage (n = 8) or construction of a new
anastomosis (n = 8); five of these patients died. Finally, in three
patients, the anastomosis was excised with either remnant ligation
or drainage; two of these patients died. Bachellier et al. reported
their experience with 12 patients with grade C PF following pan-
creaticojejunostomy reconstruction, all of whom underwent sur-
gical revision.35 Eight of these patients underwent completion
pancreatectomy, with associated mortality of 50%, and four later
patients were revised to pancreaticogastrostomy, with no mortal-
ity.35 By contrast, van Berg Henegouwen and colleagues, in a series
of severe PF, noted the superiority of completion pancreatectomy
over either percutaneous or surgical drainage in terms of a reduc-
tion in mortality.32 Given the paucity of information relative to
treatment specific to grade C PF, optimal management algo-
rithms, both operative and non-operative, relative to these fistulae
remain elusive and will require further study.
The outcome of grade C PF deserves special mention. In the
present review, the need for reoperation was substantial in
common with results in most but not all series.12,28,34,35 A total of
35% of patients who developed this complication died, and grade
C PF accounted for 41% of all deaths in the 2706 patients
reviewed. Excessive mortality has been noted in other series.34,35
This is particularly concerning given that the underlying pathol-
ogy associated with these fistulae is often associated with more
favourable prognoses relative to that of pancreatic adenocarci-
noma. A secondary but no less important concern refers to the
delay in functional recovery in these patients. Whether they are
managed non-operatively or with surgical intervention, grade C
PF is uniformly associated with a prolonged hospital stay and
greater cost.12,30,34 Details of the time to ultimate physical recovery
and delay in the institution of adjuvant therapy remain unknown,
but a negative impact on both might be anticipated.
There are several limitations to this study. Firstly, systematic
reviews are always potentially subject to publication bias. Sec-
ondly, the initial literature search brought up 12 articles published
in languages other than English, which the present authors were
unable to evaluate and thus this review was limited to studies
published in English. It is possible that one or two of the articles
published in other languages were unfairly excluded, but their
inclusion is unlikely to change the present results dramatically.
Thirdly, most articles included in this review were retrospective
case series and it is possible that the ISGPF definition and grading
system were not accurately applied to all patients despite the best
efforts of the investigators.
Grade C PF following PD, although uncommon, occurs with a
defined incidence and is associated with substantial morbidity,
prolonged hospitalization, delayed recovery, and mortality. Many
patient-related and operative risk factors for the development of
these fistulae have been elucidated. Future progress will require
the application of meticulous attention to the recording and
reporting of patient-, pancreas- and surgery-related factors asso-
ciated with these fistulae. It is hoped that clinical trials to evaluate
reconstruction strategies or surgical adjuncts that might improve
outcomes in this patient population, and strategies for the treat-
ment of PF if it does occur, will evolve.
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